Literature DB >> 12871688

Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention.

Jorge R Kizer1, Manoj R Muttrej, William H Matthai, Joseph McConnell, Heather Nardone, Ali F Sonel, Martin G Keane, Robert L Wilensky.   

Abstract

AIMS: To investigate the long-term prognostic significance of pre- and post-procedure troponin T (TnT) elevations in patients undergoing percutaneous coronary intervention (PCI). METHODS AND
RESULTS: TnT and CK-MB were measured pre- and post-procedure in 212 patients undergoing PCI. Major adverse events (composite of death, myocardial infarction and revascularization) were ascertained 6 years later. Pre-procedural TnT was a significant independent predictor of time to major events (hazard ratio [HR] 1.75, 95% confidence interval [CI] 1.16-2.64) and death or myocardial infarction. Post-procedural TnT elevation above normal was the only independent predictor of the primary end-point at 1 year (HR 2.39, 95% CI 1.09-5.26) but was not significantly related to event-free survival throughout follow-up. Post-PCI elevation of TnT 5x above normal, however, did significantly predict time to events during the entirety of follow-up. By contrast, CK-MB was not an independent predictor in any of the analyses.
CONCLUSIONS: Our study confirms the long-term prognostic value of pre-procedural TnT elevation in patients undergoing PCI, and demonstrates the superior predictive ability of a post-procedural increase in TnT 5x normal for long-term adverse events. Whether the prognostic significance of smaller post-procedural TnT elevations extends beyond the intermediate-term awaits further investigation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12871688     DOI: 10.1016/s0195-668x(03)00258-6

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  12 in total

1.  Prognostic role of cardiac troponin I after percutaneous coronary intervention in stable coronary disease.

Authors:  T Nageh; R A Sherwood; B M Harris; M R Thomas
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

2.  Safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention.

Authors:  José G Díez; Hector M Medina; Benjamin Y C Cheong; Lawrence O'Meallie; James J Ferguson
Journal:  Tex Heart Inst J       Date:  2009

3.  Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI).

Authors:  Issam D Moussa; Lloyd W Klein; Binita Shah; Roxana Mehran; Michael J Mack; Emmanouil S Brilakis; John P Reilly; Gilbert Zoghbi; Elizabeth Holper; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2013-10-22       Impact factor: 24.094

4.  Significant decrease in lipid core burden index following balloon dilation was associated with the leakage of cholesterol crystals in a patient: a case report.

Authors:  Soshi Moriya; Kikuo Isoda; Tomotaka Dohi; Shinya Okazaki
Journal:  Eur Heart J Case Rep       Date:  2020-06-17

5.  Rise of serum troponin levels following uncomplicated elective percutaneous coronary interventions in patients without clinical and procedural signs suggestive of myocardial necrosis.

Authors:  Ali Buturak; Aleks Degirmencioglu; Ozgur Surgit; Ali Rıza Demir; Huseyin Karakurt; Mehmet Erturk; Selcuk Yazıcı; Mustafa Serteser; Tugrul Norgaz; Sevket Gorgulu
Journal:  Postepy Kardiol Interwencyjnej       Date:  2016-02-11       Impact factor: 1.426

6.  Effect of Remote Ischemic Preconditioning on Troponin I in CABG.

Authors:  Fatemeh Javaherforoosh Zadeh; Mohsen Moadeli; Mansoor Soltanzadeh; Farahzad Janatmakan
Journal:  Anesth Pain Med       Date:  2017-08-21

Review 7.  Effect of Remote Ischemic Preconditioning on Perioperative Cardiac Events in Patients Undergoing Elective Percutaneous Coronary Intervention: A Meta-Analysis of 16 Randomized Trials.

Authors:  Xiangming Wang; Na Kong; Chuanwei Zhou; Deeraj Mungun; Zakaria Iyan; Yan Guo; Zhijian Yang
Journal:  Cardiol Res Pract       Date:  2017-09-14       Impact factor: 1.866

8.  Preconditioning by isoflurane as a volatile anesthetic in elective coronary artery bypass surgery.

Authors:  Amjad Kiani; Mohsen Mirmohammad Sadeghi; Mojgan Gharipour; Niloofar Farahmand; Laleh Hoveida
Journal:  ARYA Atheroscler       Date:  2013-05

9.  Biomarkers and Bioassays for Cardiovascular Diseases: Present and Future.

Authors:  Derek S Sim; Hsiao Lieu; Patrick Andre
Journal:  Biomark Insights       Date:  2008-05-19

Review 10.  Risks and complications of coronary angiography: a comprehensive review.

Authors:  Morteza Tavakol; Salman Ashraf; Sorin J Brener
Journal:  Glob J Health Sci       Date:  2012-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.